Gustav Magrinat

Also affiliated with Virginia Cancer Institute, NSABP Foundation

Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Primary results of NRG Oncology / NSABP B-43: Phase III trial comparing concurrent trastuzumab (T) and radiation therapy (RT) with RT alone for women with HER2-positive ductal carcinoma in situ (DCIS) after lumpectomy.”.

Primary results of NRG Oncology / NSABP B-43: Phase III trial comparing concurrent trastuzumab (T) and radiation therapy (RT) with RT alone for women with HER2-positive ductal carcinoma in situ (DCIS) after lumpectomy.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.508

N/A

0DataRank · unranked

9 citations

Stewart Anderson, Kalliopi P. Siziopikou, Douglas W. Arthur, Thomas B. Julian, Rachel Rabinovitch +15 more

Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907

UNC Libraries(2020)10.17615/8he8-0367

N/A

0DataRank · unranked

0 citations

Stuart M. Lichtman, Aminah Jatoi, Arti Hurria, Constance Cirrincione, Antonio C. Wolff +6 more